|
시장보고서
상품코드
1397195
수송 배지 시장 : 시장 규모, 점유율 분석 - 제품 유형별, 용도별, 적응증별, 최종 사용자별 : 세계의 산업 수요 예측(-2030년)Transport Media Market Size and Share Analysis by Product Type, Application, Indication, End User - Global Industry Demand Forecast to 2030 |
||||||
세계의 수송 배지 시장 규모는 2023년에는 31억 130만 달러에 이르렀고, 2030년에는 4.6%의 CAGR로 성장할 전망이며, 42억 1,060만 달러로 확대될 것으로 추정됩니다.
이 업계의 성장 배경은 바이러스 성 질환에 대한 연구 개발 증가, 전임상 및 진단 테스트의 필요성 증가, 인플루엔자 및 헤르페스와 같은 감염성 질환의 급증을 포함합니다.
예를 들어, 2022년에는 세계에서 약 40만 명이 독감으로 사망했습니다. 마찬가지로 약 40억 명이 헤르페스를 앓고 있습니다. 또한, 검사 키트의 수용을 강화하기 위한 정부의 이니셔티브이 증가하고 있는 것도 이 업계를 뒷받침하고 있습니다.
제품 유형별로는 바이러스 수송 배지의 카테고리가 2023년에는 35%의 점유율을 차지해 업계를 선도했습니다. 이것은 COVID-19나 원숭이두와 같은 감염의 예기치 않은 발생이 감염자의 검사 및 진단의 필요성을 높이고 있기 때문이라고 생각됩니다.
게다가 COVID-19의 대유행 시 치료 및 진단에 대한 의식이 높아짐에 따라 다른 다양한 감염을 검출하기 위한 관련 제품에 대한 요구가 높아지고 있습니다.
적응증별로, 바이러스성 질환의 카테고리가 수송 배지 시장을 독점하고 있습니다. 게다가 이 범주는 지난 10년 동안 가장 빠른 속도로 발전했습니다. 이는 주로 인플루엔자, 원두두, 헤르페스, COVID-19, 호흡기 합포체 바이러스, 수두 대상 포진 등 바이러스성 질환의 발생률이 급상승하고 있기 때문으로 보입니다.
게다가 이러한 질병 중에서도 인플루엔자와 COVID-19 바이러스는 가장 감염성이 강한 호흡기계의 질병이기 때문에 세계적으로 심각한 우려 물질이 되고 있습니다.
최종 사용자별로 진단 실험실 범주는 업계에서 가장 큰 점유율을 차지합니다. 이는 COVID-19의 진단뿐만 아니라 검사에 대한 요구가 증가하고 있기 때문입니다. 이것은 진단 실험실의 설립을 뒷받침하고 일량을 증가시키고 있습니다.
북미는 업계를 지배하고 있습니다. 이는 진단 테스트의 급증, 감염증에 관한 연구개발 증가, 확립된 의료제도, 다수의 제약 및 바이오테크놀러지 기업의 존재 때문입니다.
기본적으로 감염, 특히 바이러스성 질환의 급증은 각 기업의 수익 창출을 돕는 주요 요인입니다.
아시아태평양은 지난 10년간 라임병, 결핵 및 COVID-19와 같은 감염증의 유병률이 상승하고 있기 때문에 가장 빠른 CAGR로 성장한 것으로 보입니다.
또한, 아시아태평양(특히 인도와 중국)에서 감염 환자의 수가 매우 많습니다. 따라서 진단의 방대한 미충족 요구를 충족시키려고 여러 기업이 참가해 왔습니다.
바이러스성 질환의 연구개발 증가 및 감염증의 발생률이 높아짐에 따라, 수송 배지 산업은 향후 수년간 계속 진보할 것으로 보입니다.
목차
제1장 분석 범위
제2장 분석 방법
제3장 주요 요약
제4장 시장 지표
제5장 업계 전망
- 시장 역학
- 동향
- 성장 촉진요인
- 억제요인 및 과제
- 성장 촉진요인 및 억제요인의 영향 분석
- 신형 코로나 바이러스 감염(COVID-19)의 영향
- Porter's Five Forces 분석
제6장 세계 시장
- 개요
- 시장 수익 : 제품 유형별(2017-2030년)
- 시장 수익 : 용도별(2017-2030년)
- 시장 수익 : 적응증별(2017-2030년)
- 시장 수익 : 최종 사용자별(2017-2030년)
- 시장 수익 : 지역별(2017-2030년)
제7장 북미 시장
- 개요
- 시장 수익 : 제품 유형별(2017-2030년)
- 시장 수익 : 용도별(2017-2030년)
- 시장 수익 : 적응증별(2017-2030년)
- 시장 수익 : 최종 사용자별(2017-2030년)
- 시장 수익 : 국가별(2017-2030년)
제8장 유럽 시장
제9장 아시아태평양 시장
제10장 중남미 시장
제11장 중동 및 아프리카 시장
제12장 미국 시장
- 개요
- 시장 수익 : 제품 유형별(2017-2030년)
- 시장 수익 : 용도별(2017-2030년)
- 시장 수익 : 적응증별(2017-2030년)
- 시장 수익 : 최종 사용자별(2017-2030년)
제13장 캐나다 시장
제14장 독일 시장
제15장 프랑스 시장
제16장 영국 시장
제17장 이탈리아 시장
제18장 스페인 시장
제19장 일본 시장
제20장 중국 시장
제21장 인도 시장
제22장 호주 시장
제23장 한국 시장
제24장 브라질 시장
제25장 멕시코 시장
제26장 사우디아라비아 시장
제27장 남아프리카 시장
제28장 아랍에미리트(UAE) 시장
제29장 경쟁 구도
- 시장 진출기업 및 그 제공 내용의 일람
- 주요 기업의 경쟁 벤치마킹
- 주요 기업의 제품 벤치마킹
- 최근의 전략 전개 상황
제30장 기업 프로파일
- Thermo Fisher Scientific Inc.
- Puritan Medical Products LLC
- Becton, Dickinson and Company
- COPAN Diagnostics Inc.
- Laboratory Corporation of America Holdings
- HiMedia Laboratories Pvt. Ltd.
- Trinity Biotech plc
- EKF Diagnostics Holdings plc
- Alpha Teknova Inc.
- Vircell SL
- Medical Wire & Equipment
- Lucence Health Inc.
- Merck KGaA
- Wuxi AppTec Co. Ltd.
- Bio-Rad Laboratories Inc.
제31장 부록
AJY 24.01.02The transport media market is estimated to reach USD 3,101.3 million in 2023, which will increase to USD 4,210.6 million, with a 4.6% compound annual growth rate, by 2030.
The growth of this industry is because of the rising R&D on viral illnesses, increasing need for pre-clinical and diagnostic testing, and the surging occurrence of infectious ailments like influenza and herpes.
For example, in 2022, around 400,000 individuals died from influenza globally. Likewise, approximately 4 billion individuals have herpes. Moreover, the growing count of government initiatives to enhance the acceptance of testing kits is also boosting the industry.
The viral transport media category, based on product type, is leading the industry, with a 35% share, in 2023. This can be because of the unexpected outbreak of infectious ailments like COVID-19 and monkeypox, which boost the requirement for testing and diagnosis among the infected people.
Furthermore, the growing consciousness of treatment and diagnosis during the pandemic of COVID-19 has increased the requirement for related products for detecting various other infections.
The viral diseases category, on the basis of indication, is dominating the transport media market. Furthermore, the category will also advance at the fastest rate during this decade. This can be primarily because of the surging incidence of viral ailments like influenza, monkeypox, herpes, COVID-19, respiratory syncytial virus, and Varicella zoster.
Moreover, among these ailments, the influenza and COVID-19 virus are the most contagious respiratory ailments, therefore, they are a serious cause for worry globally.
The diagnostic laboratories category, based on end user, is the largest contributor to the industry. This is because of the increase in the need for testing as well as diagnosis of COVID-19. This has powered the formation of diagnostic labs and increased their workload.
North America is dominating the industry. This is because of the surging number of diagnostic tests, rising R&D on infectious ailments, well-established healthcare system, and the existence of numerous pharma and biotech businesses.
Basically, the surging occurrence of infectious illnesses, particularly viral ailments, is a main factor that assists in revenue generation for industry players.
APAC will advance at the fastest compound annual growth rate during this decade, because of the rising prevalence of infectious illnesses like Lyme disease, tuberculosis, and COVID-19.
Moreover, the number of people with infectious illnesses is quite high in APAC, particularly in India and China. Therefore, several industry players have arrived to satisfy the vast unmet necessity for diagnosis.
It is because of the increasing research & development in viral ailments and the mounting incidence of infectious illnesses, the transport media industry will continue to progress in the coming years.
Table of Contents
Chapter 1. Research Scope
- 1.1. Research Objectives
- 1.2. Market Definition
- 1.3. Analysis Period
- 1.4. Market Size Breakdown by Segments
- 1.4.1. Market size breakdown, by product type
- 1.4.2. Market size breakdown, by application
- 1.4.3. Market size breakdown, by indication
- 1.4.4. Market size breakdown, by end user
- 1.4.5. Market size breakdown, by region
- 1.4.6. Market size breakdown, by country
- 1.5. Market Data Reporting Unit
- 1.5.1. Value
- 1.6. Key Stakeholders
Chapter 2. Research Methodology
- 2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence database
- 2.2. Primary Research
- 2.3. Market Size Estimation
- 2.4. Data Triangulation
- 2.5. Currency Conversion Rates
- 2.6. Assumptions for the Study
- 2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Market Indicators
Chapter 5. Industry Outlook
- 5.1. Market Dynamics
- 5.1.1. Trends
- 5.1.2. Drivers
- 5.1.3. Restraints/challenges
- 5.1.4. Impact analysis of drivers/restraints
- 5.2. Impact of COVID-19
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Bargaining power of buyers
- 5.3.2. Bargaining power of suppliers
- 5.3.3. Threat of new entrants
- 5.3.4. Intensity of rivalry
- 5.3.5. Threat of substitutes
Chapter 6. Global Market
- 6.1. Overview
- 6.2. Market Revenue, by Product Type (2017-2030)
- 6.3. Market Revenue, by Application (2017-2030)
- 6.4. Market Revenue, by Indication (2017-2030)
- 6.5. Market Revenue, by End User (2017-2030)
- 6.6. Market Revenue, by Region (2017-2030)
Chapter 7. North America Market
- 7.1. Overview
- 7.2. Market Revenue, by Product Type (2017-2030)
- 7.3. Market Revenue, by Application (2017-2030)
- 7.4. Market Revenue, by Indication (2017-2030)
- 7.5. Market Revenue, by End User (2017-2030)
- 7.6. Market Revenue, by Country (2017-2030)
Chapter 8. Europe Market
- 8.1. Overview
- 8.2. Market Revenue, by Product Type (2017-2030)
- 8.3. Market Revenue, by Application (2017-2030)
- 8.4. Market Revenue, by Indication (2017-2030)
- 8.5. Market Revenue, by End User (2017-2030)
- 8.6. Market Revenue, by Country (2017-2030)
Chapter 9. APAC Market
- 9.1. Overview
- 9.2. Market Revenue, by Product Type (2017-2030)
- 9.3. Market Revenue, by Application (2017-2030)
- 9.4. Market Revenue, by Indication (2017-2030)
- 9.5. Market Revenue, by End User (2017-2030)
- 9.6. Market Revenue, by Country (2017-2030)
Chapter 10. LATAM Market
- 10.1. Overview
- 10.2. Market Revenue, by Product Type (2017-2030)
- 10.3. Market Revenue, by Application (2017-2030)
- 10.4. Market Revenue, by Indication (2017-2030)
- 10.5. Market Revenue, by End User (2017-2030)
- 10.6. Market Revenue, by Country (2017-2030)
Chapter 11. MEA Market
- 11.1. Overview
- 11.2. Market Revenue, by Product Type (2017-2030)
- 11.3. Market Revenue, by Application (2017-2030)
- 11.4. Market Revenue, by Indication (2017-2030)
- 11.5. Market Revenue, by End User (2017-2030)
- 11.6. Market Revenue, by Country (2017-2030)
Chapter 12. U.S. Market
- 12.1. Overview
- 12.2. Market Revenue, by Product Type (2017-2030)
- 12.3. Market Revenue, by Application (2017-2030)
- 12.4. Market Revenue, by Indication (2017-2030)
- 12.5. Market Revenue, by End User (2017-2030)
Chapter 13. Canada Market
- 13.1. Overview
- 13.2. Market Revenue, by Product Type (2017-2030)
- 13.3. Market Revenue, by Application (2017-2030)
- 13.4. Market Revenue, by Indication (2017-2030)
- 13.5. Market Revenue, by End User (2017-2030)
Chapter 14. Germany Market
- 14.1. Overview
- 14.2. Market Revenue, by Product Type (2017-2030)
- 14.3. Market Revenue, by Application (2017-2030)
- 14.4. Market Revenue, by Indication (2017-2030)
- 14.5. Market Revenue, by End User (2017-2030)
Chapter 15. France Market
- 15.1. Overview
- 15.2. Market Revenue, by Product Type (2017-2030)
- 15.3. Market Revenue, by Application (2017-2030)
- 15.4. Market Revenue, by Indication (2017-2030)
- 15.5. Market Revenue, by End User (2017-2030)
Chapter 16. U.K. Market
- 16.1. Overview
- 16.2. Market Revenue, by Product Type (2017-2030)
- 16.3. Market Revenue, by Application (2017-2030)
- 16.4. Market Revenue, by Indication (2017-2030)
- 16.5. Market Revenue, by End User (2017-2030)
Chapter 17. Italy Market
- 17.1. Overview
- 17.2. Market Revenue, by Product Type (2017-2030)
- 17.3. Market Revenue, by Application (2017-2030)
- 17.4. Market Revenue, by Indication (2017-2030)
- 17.5. Market Revenue, by End User (2017-2030)
Chapter 18. Spain Market
- 18.1. Overview
- 18.2. Market Revenue, by Product Type (2017-2030)
- 18.3. Market Revenue, by Application (2017-2030)
- 18.4. Market Revenue, by Indication (2017-2030)
- 18.5. Market Revenue, by End User (2017-2030)
Chapter 19. Japan Market
- 19.1. Overview
- 19.2. Market Revenue, by Product Type (2017-2030)
- 19.3. Market Revenue, by Application (2017-2030)
- 19.4. Market Revenue, by Indication (2017-2030)
- 19.5. Market Revenue, by End User (2017-2030)
Chapter 20. China Market
- 20.1. Overview
- 20.2. Market Revenue, by Product Type (2017-2030)
- 20.3. Market Revenue, by Application (2017-2030)
- 20.4. Market Revenue, by Indication (2017-2030)
- 20.5. Market Revenue, by End User (2017-2030)
Chapter 21. India Market
- 21.1. Overview
- 21.2. Market Revenue, by Product Type (2017-2030)
- 21.3. Market Revenue, by Application (2017-2030)
- 21.4. Market Revenue, by Indication (2017-2030)
- 21.5. Market Revenue, by End User (2017-2030)
Chapter 22. Australia Market
- 22.1. Overview
- 22.2. Market Revenue, by Product Type (2017-2030)
- 22.3. Market Revenue, by Application (2017-2030)
- 22.4. Market Revenue, by Indication (2017-2030)
- 22.5. Market Revenue, by End User (2017-2030)
Chapter 23. South Korea Market
- 23.1. Overview
- 23.2. Market Revenue, by Product Type (2017-2030)
- 23.3. Market Revenue, by Application (2017-2030)
- 23.4. Market Revenue, by Indication (2017-2030)
- 23.5. Market Revenue, by End User (2017-2030)
Chapter 24. Brazil Market
- 24.1. Overview
- 24.2. Market Revenue, by Product Type (2017-2030)
- 24.3. Market Revenue, by Application (2017-2030)
- 24.4. Market Revenue, by Indication (2017-2030)
- 24.5. Market Revenue, by End User (2017-2030)
Chapter 25. Mexico Market
- 25.1. Overview
- 25.2. Market Revenue, by Product Type (2017-2030)
- 25.3. Market Revenue, by Application (2017-2030)
- 25.4. Market Revenue, by Indication (2017-2030)
- 25.5. Market Revenue, by End User (2017-2030)
Chapter 26. Saudi Arabia Market
- 26.1. Overview
- 26.2. Market Revenue, by Product Type (2017-2030)
- 26.3. Market Revenue, by Application (2017-2030)
- 26.4. Market Revenue, by Indication (2017-2030)
- 26.5. Market Revenue, by End User (2017-2030)
Chapter 27. South Africa Market
- 27.1. Overview
- 27.2. Market Revenue, by Product Type (2017-2030)
- 27.3. Market Revenue, by Application (2017-2030)
- 27.4. Market Revenue, by Indication (2017-2030)
- 27.5. Market Revenue, by End User (2017-2030)
Chapter 28. U.A.E. Market
- 28.1. Overview
- 28.2. Market Revenue, by Product Type (2017-2030)
- 28.3. Market Revenue, by Application (2017-2030)
- 28.4. Market Revenue, by Indication (2017-2030)
- 28.5. Market Revenue, by End User (2017-2030)
Chapter 29. Competitive Landscape
- 29.1. List of Market Players and their Offerings
- 29.2. Competitive Benchmarking of Key Players
- 29.3. Product Benchmarking of Key Players
- 29.4. Recent Strategic Developments
Chapter 30. Company Profiles
- 30.1. Thermo Fisher Scientific Inc.
- 30.1.1. Business overview
- 30.1.2. Product and service offerings
- 30.1.3. Key financial summary
- 30.2. Puritan Medical Products LLC
- 30.2.1. Business overview
- 30.2.2. Product and service offerings
- 30.3. Becton, Dickinson and Company
- 30.3.1. Business overview
- 30.3.2. Product and service offerings
- 30.3.3. Key financial summary
- 30.4. COPAN Diagnostics Inc.
- 30.4.1. Business overview
- 30.4.2. Product and service offerings
- 30.5. Laboratory Corporation of America Holdings
- 30.5.1. Business overview
- 30.5.2. Product and service offerings
- 30.5.3. Key financial summary
- 30.6. HiMedia Laboratories Pvt. Ltd.
- 30.6.1. Business overview
- 30.6.2. Product and service offerings
- 30.7. Trinity Biotech plc
- 30.7.1. Business overview
- 30.7.2. Product and service offerings
- 30.7.3. Key financial summary
- 30.8. EKF Diagnostics Holdings plc
- 30.8.1. Business overview
- 30.8.2. Product and service offerings
- 30.8.3. Key financial summary
- 30.9. Alpha Teknova Inc.
- 30.9.1. Business overview
- 30.9.2. Product and service offerings
- 30.9.3. Key financial summary
- 30.10. Vircell S.L.
- 30.10.1. Business overview
- 30.10.2. Product and service offerings
- 30.11. Medical Wire & Equipment
- 30.11.1. Business overview
- 30.11.2. Product and service offerings
- 30.12. Lucence Health Inc.
- 30.12.1. Business overview
- 30.12.2. Product and service offerings
- 30.13. Merck KGaA
- 30.13.1. Business overview
- 30.13.2. Product and service offerings
- 30.13.3. Key financial summary
- 30.14. Wuxi AppTec Co. Ltd.
- 30.14.1. Business overview
- 30.14.2. Product and service offerings
- 30.14.3. Key financial summary
- 30.15. Bio-Rad Laboratories Inc.
- 30.15.1. Business overview
- 30.15.2. Product and service offerings
- 30.15.3. Key financial summary
Chapter 31. Appendix
- 31.1. Abbreviations
- 31.2. Sources and References
- 31.3. Related Reports
